Dengxiang Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dengxiang Liu has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
Chengyu Liu
Graduate School of Hebei Medical University, Shijiazhuang, China
4 shared publicationsJinlong Li
Hebei Provincial Key Laboratory of Cirrhosis and Portal Hypertension, Xingtai People’s Hospital of Hebei Medical University, Xingtai, Hebei, China
3 shared publicationsJitao Wang
Xingtai People’s Hospital of Hebei Medical University
3 shared publicationsZhi Li
Department of Infection Management, North China Healthcare Group Xingtai General Hospital, Xingtai, Hebei, China
3 shared publicationsChangjing Wang
Department of Gastrointestinal Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, China
2 shared publicationsFengxiao Gao
Xingtai People’s Hospital of Hebei Medical University
2 shared publications
Latest Publications
- Open Access
- 13 October 2026
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 32 (6) , 1-11
Associations of reticulocyte hemoglobin equivalent with erythrocyte indices and serum ferritin in anemic patients with hepatocellular carcinoma: A retrospective study
Cancer‑related anemia is common in patients with hepatocellular carcinoma (HCC), and its pathogenesis is complex due to the coexistence of chronic liver disease, portal hypertension, hypersplenism, inflammation, nutritional disorders and tumor‑related factors. The present retrospective study characterized anemia morphology in 96 anemic patients with HCC before initiation of their first antitumor therapy, and examined the associations of reticulocyte hemoglobin equivalent (RET‑He) with erythrocyte indices and serum ferritin (SF), with a focus on whether RET‑He and SF displayed distinct patterns of association with hematological parameters. The data collected included sex, age, Barcelona Clinic Liver Cancer stage, Child‑Pugh grade, splenomegaly/hypersplenism, hemoglobin (Hb) concentration, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), MCH concentration (MCHC), absolute reticulocyte count (RET#), RET‑He and SF. Patients were compared by anemia severity, morphological type and RET‑He level, and Spearman'a correlation was used to assess relationships between RET‑He and other parameters. Mild, moderate and severe anemia occurred in 41 (42.71%), 52 (54.17%) and 3 (3.13%) patients, respectively. Macrocytic, normocytic, simple microcytic and microcytic hypochromic anemia were found in 29 (30.21%), 40 (41.67%), 5 (5.21%) and 22 (22.92%) patients, respectively. A total of 26 patients (27.08%) had RET‑He ≤29 pg, and the median SF was 248.5 ng/ml (interquartile range, 146.8‑346.0 ng/ml). Compared with mild anemia, moderate‑to‑severe anemia was associated with lower MCV, MCH, MCHC and RET‑He, and higher proportions of RET‑He ≤29 pg and microcytic hypochromic anemia (all P<0.05). RET‑He was lowest in the microcytic group (P<0.001). Patients with RET‑He ≤29 pg had lower Hb concentration, MCV, MCH, MCHC and RET# (all P<0.05). Spearman's analysis indicated that RET‑He was positively correlated with Hb concentration, MCV, MCH, MCHC and RET# (all P<0.05), but not with SF (P=0.408). In conclusion, anemia in patients with HCC demonstrated heterogeneous morphological patterns, and microcytic anemia was associated with lower RET‑He levels. RET‑He was associated with erythrocyte indices related to hemoglobinization, whereas no such association was observed with SF. The dissociation between RET‑He and SF suggests that these markers may reflect different aspects of iron metabolism and erythropoiesis in HCC. RET‑He may offer complementary information on erythroid hemoglobinization not directly captured by SF, but its clinical utility requires further validation. SF should be interpreted cautiously in the context of chronic liver disease, inflammation and tumor‑related factors.
- 13 October 2026
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 32 (6) , 1-11
Open AccessAssociations of reticulocyte hemoglobin equivalent with erythrocyte indices and serum ferritin in anemic patients with hepatocellular carcinoma: A retrospective study
Cancer‑related anemia is common in patients with hepatocellular carcinoma (HCC), and its pathogenesis is complex due to the coexistence of chronic liver disease, portal hypertension, hypersplenism, inflammation, nutritional disorders and tumor‑related factors. The present retrospective study characterized anemia morphology in 96 anemic patients with HCC before initiation of their first antitumor therapy, and examined the associations of reticulocyte hemoglobin equivalent (RET‑He) with erythrocyte indices and serum ferritin (SF), with a focus on whether RET‑He and SF displayed distinct patterns of association with hematological parameters. The data collected included sex, age, Barcelona Clinic Liver Cancer stage, Child‑Pugh grade, splenomegaly/hypersplenism, hemoglobin (Hb) concentration, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), MCH concentration (MCHC), absolute reticulocyte count (RET#), RET‑He and SF. Patients were compared by anemia severity, morphological type and RET‑He level, and Spearman'a correlation was used to assess relationships between RET‑He and other parameters. Mild, moderate and severe anemia occurred in 41 (42.71%), 52 (54.17%) and 3 (3.13%) patients, respectively. Macrocytic, normocytic, simple microcytic and microcytic hypochromic anemia were found in 29 (30.21%), 40 (41.67%), 5 (5.21%) and 22 (22.92%) patients, respectively. A total of 26 patients (27.08%) had RET‑He ≤29 pg, and the median SF was 248.5 ng/ml (interquartile range, 146.8‑346.0 ng/ml). Compared with mild anemia, moderate‑to‑severe anemia was associated with lower MCV, MCH, MCHC and RET‑He, and higher proportions of RET‑He ≤29 pg and microcytic hypochromic anemia (all P<0.05). RET‑He was lowest in the microcytic group (P<0.001). Patients with RET‑He ≤29 pg had lower Hb concentration, MCV, MCH, MCHC and RET# (all P<0.05). Spearman's analysis indicated that RET‑He was positively correlated with Hb concentration, MCV, MCH, MCHC and RET# (all P<0.05), but not with SF (P=0.408). In conclusion, anemia in patients with HCC demonstrated heterogeneous morphological patterns, and microcytic anemia was associated with lower RET‑He levels. RET‑He was associated with erythrocyte indices related to hemoglobinization, whereas no such association was observed with SF. The dissociation between RET‑He and SF suggests that these markers may reflect different aspects of iron metabolism and erythropoiesis in HCC. RET‑He may offer complementary information on erythroid hemoglobinization not directly captured by SF, but its clinical utility requires further validation. SF should be interpreted cautiously in the context of chronic liver disease, inflammation and tumor‑related factors.
- Open Access
- 26 August 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1881556
Association between serum tumor necrosis factor-alpha levels and rheumatoid arthritis-associated interstitial lung disease: a cross-sectional study
Background: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is one of the most severe extra-articular complications of rheumatoid arthritis (RA). Although tumor necrosis factor-α (TNF-α) plays a central role in RA pathogenesis, its relationship with RA-ILD remains uncertain. This study aimed to investigate the association between serum TNF-α levels and RA-ILD, with a focus on sex-stratified patterns. Methods: We performed a cross-sectional study that initially included 1,191 consecutive RA inpatients at Xingtai People’s Hospital between March 2022 and December 2024. Clinical and laboratory data were extracted from electronic medical records. RA-ILD was diagnosed using high-resolution computed tomography, with subtypes classified by consensus. Multivariable logistic regression and generalized additive models were used to assess the association of TNF-α with RA-ILD. Serum TNF-α was natural log-transformed (ln) to improve linearity and reduce the influence of extreme values. Results: After exclusions, 790 patients were included in the final analysis, of whom 149 (18.86%) had RA-ILD, with a higher prevalence in males than in females (30.68% vs 15.47%). In sex-stratified analyses, after adjusting for age, disease duration, rheumatoid factor, and anti-citrullinated protein antibody in both sexes, and additionally adjusting for smoking in males, serum TNF-α was associated with RA-ILD in females (highest vs lowest tertile: OR = 1.96, 95% CI: 1.10 – 3.48; P for trend < 0.01). This association followed a nonlinear pattern, with an exploratory inflection point above which elevated TNF-α showed a positive association with increased odds of RA-ILD. In males, no statistically significant association was observed across all models. However, the formal sex ×ln(TNF-α) interaction term was not statistically significant ( P = 0.08). Conclusion: In sex-stratified analyses, serum TNF-α was associated with RA-ILD in females, exhibiting a nonlinear relationship with a potential inflection point; no statistically significant association was observed in males. However, as the interaction testing did not confirm a statistically significant sex difference, these findings are exploratory and warrant further prospective validation in larger cohorts.
- 26 August 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1881556
Open AccessAssociation between serum tumor necrosis factor-alpha levels and rheumatoid arthritis-associated interstitial lung disease: a cross-sectional study
Background: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is one of the most severe extra-articular complications of rheumatoid arthritis (RA). Although tumor necrosis factor-α (TNF-α) plays a central role in RA pathogenesis, its relationship with RA-ILD remains uncertain. This study aimed to investigate the association between serum TNF-α levels and RA-ILD, with a focus on sex-stratified patterns. Methods: We performed a cross-sectional study that initially included 1,191 consecutive RA inpatients at Xingtai People’s Hospital between March 2022 and December 2024. Clinical and laboratory data were extracted from electronic medical records. RA-ILD was diagnosed using high-resolution computed tomography, with subtypes classified by consensus. Multivariable logistic regression and generalized additive models were used to assess the association of TNF-α with RA-ILD. Serum TNF-α was natural log-transformed (ln) to improve linearity and reduce the influence of extreme values. Results: After exclusions, 790 patients were included in the final analysis, of whom 149 (18.86%) had RA-ILD, with a higher prevalence in males than in females (30.68% vs 15.47%). In sex-stratified analyses, after adjusting for age, disease duration, rheumatoid factor, and anti-citrullinated protein antibody in both sexes, and additionally adjusting for smoking in males, serum TNF-α was associated with RA-ILD in females (highest vs lowest tertile: OR = 1.96, 95% CI: 1.10 – 3.48; P for trend < 0.01). This association followed a nonlinear pattern, with an exploratory inflection point above which elevated TNF-α showed a positive association with increased odds of RA-ILD. In males, no statistically significant association was observed across all models. However, the formal sex ×ln(TNF-α) interaction term was not statistically significant ( P = 0.08). Conclusion: In sex-stratified analyses, serum TNF-α was associated with RA-ILD in females, exhibiting a nonlinear relationship with a potential inflection point; no statistically significant association was observed in males. However, as the interaction testing did not confirm a statistically significant sex difference, these findings are exploratory and warrant further prospective validation in larger cohorts.
- Open Access
- 1 May 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-13
Association Between Neutrophil Percentage to Albumin Ratio and Disease Activity in Hospitalized Patients with Rheumatoid Arthritis: A Cross-Sectional Study
The neutrophil percentage-to-albumin ratio (NPAR) is a readily accessible yet underexplored inflammatory marker in rheumatoid arthritis (RA). This study aimed to explore the association of NPAR with disease activity and to evaluate its performance in identifying high disease activity. A cross-sectional analysis was performed among 1,191 hospitalized RA patients admitted to Xingtai People’s Hospital between March 2022 and December 2024. NPAR was computed as (neutrophil percentage × 100) divided by serum albumin (g/dL). Disease activity was quantified using the 28-joint Disease Activity Score (DAS28) by erythrocyte sedimentation rate (DAS28-ESR) and C-reactive protein (DAS28-CRP). Multiple linear regression models were applied to determine the independent association between NPAR and disease activity, and receiver operating characteristic curve analyses were conducted to examine the ability of NPAR to identify high disease activity. 989 patients met the inclusion criteria for final analysis (average age 57.6 years; 78.0% women), 95.6% exhibited moderate-to-high disease activity. After fully adjusting for variables, NPAR remained independently and positively associated with disease activity. Each standard deviation increase in NPAR was associated with an increase of 0.37 in DAS28-CRP and 0.34 in DAS28-ESR. A clear dose–response relationship was observed across increasing NPAR tertiles. In addition, NPAR demonstrated moderate discriminatory performance for distinguishing high from moderate disease activity, with areas under the ROC curve of 0.75 (95% CI, 0.72–0.79) for DAS28-CRP and 0.71 (95% CI, 0.68–0.75) for DAS28-ESR. Notably, NPAR showed better discriminatory ability than other conventional complete blood count-derived indices, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), platelet-to-albumin ratio (PAR), and neutrophil-to-albumin ratio (NAR). In hospitalized patients with moderate-to-high disease activity, NPAR was positively associated with RA disease activity and showed meaningful discriminatory performance for identifying high disease states.
- 1 May 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-13
Open AccessAssociation Between Neutrophil Percentage to Albumin Ratio and Disease Activity in Hospitalized Patients with Rheumatoid Arthritis: A Cross-Sectional Study
The neutrophil percentage-to-albumin ratio (NPAR) is a readily accessible yet underexplored inflammatory marker in rheumatoid arthritis (RA). This study aimed to explore the association of NPAR with disease activity and to evaluate its performance in identifying high disease activity. A cross-sectional analysis was performed among 1,191 hospitalized RA patients admitted to Xingtai People’s Hospital between March 2022 and December 2024. NPAR was computed as (neutrophil percentage × 100) divided by serum albumin (g/dL). Disease activity was quantified using the 28-joint Disease Activity Score (DAS28) by erythrocyte sedimentation rate (DAS28-ESR) and C-reactive protein (DAS28-CRP). Multiple linear regression models were applied to determine the independent association between NPAR and disease activity, and receiver operating characteristic curve analyses were conducted to examine the ability of NPAR to identify high disease activity. 989 patients met the inclusion criteria for final analysis (average age 57.6 years; 78.0% women), 95.6% exhibited moderate-to-high disease activity. After fully adjusting for variables, NPAR remained independently and positively associated with disease activity. Each standard deviation increase in NPAR was associated with an increase of 0.37 in DAS28-CRP and 0.34 in DAS28-ESR. A clear dose–response relationship was observed across increasing NPAR tertiles. In addition, NPAR demonstrated moderate discriminatory performance for distinguishing high from moderate disease activity, with areas under the ROC curve of 0.75 (95% CI, 0.72–0.79) for DAS28-CRP and 0.71 (95% CI, 0.68–0.75) for DAS28-ESR. Notably, NPAR showed better discriminatory ability than other conventional complete blood count-derived indices, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), platelet-to-albumin ratio (PAR), and neutrophil-to-albumin ratio (NAR). In hospitalized patients with moderate-to-high disease activity, NPAR was positively associated with RA disease activity and showed meaningful discriminatory performance for identifying high disease states.
- Open Access
- 4 April 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1573760
Association of blood cadmium levels with all-cause and cause-specific mortality among adults with non-alcoholic fatty liver disease: a prospective cohort study
Background: Cadmium (Cd) accumulates in the body over time, damaging organs such as the liver, kidneys, and brain. Some researchers have suggested that elevated blood Cd levels may contribute to the onset and progression of nonalcoholic fatty liver disease (NAFLD). However, only a few studies have explored the relationship between Cd exposure and long-term health outcomes in patients with NAFLD. This study aimed to evaluate the predictive value of blood cadmium levels for mortality risk in patients with NAFLD.Methods: This study analyzed data from 13,450 patients with NAFLD in the National Health and Nutrition Examination Survey (NHANES) database, covering the years 1999 to 2018. Patients were categorized into three groups based on their blood Cd levels. The relationship between blood cadmium concentrations and all-cause, cardiovascular, and cancer mortality in NAFLD patients was assessed using Cox proportional hazards regression while accounting for potential confounders. Results were visualized using Kaplan–Meier and restricted cubic spline (RCS) curves. Stratified analyses were performed for validation of the robustness of the results.Results: After adjusting for all covariates, blood Cd levels were positively associated with all-cause, cardiovascular, and cancer mortality in patients with NAFLD, showing a significant linear dose–response relationship. Specifically, for each unit increase in Log-transformed blood cadmium concentration, the risk of all-cause mortality increased by 191% (HR = 2.91, 95% CI: 2.39–3.53); cardiovascular mortality risk increased by 160% (HR = 2.6, 95% CI: 1.80–3.76); and cancer mortality risk increased by 279% (HR = 3.79, 95% CI: 2.54–5.65). Stratified analysis confirmed the robustness of these findings.Conclusion: Our study suggests that high Blood Cd levels adversely affect the prognosis of patients with NAFLD. Individuals with NAFLD should be aware of Cd exposure and take preventive measures. Moreover, stricter environmental protection policies may be necessary to reduce Cd exposure.
- 4 April 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1573760
Open AccessAssociation of blood cadmium levels with all-cause and cause-specific mortality among adults with non-alcoholic fatty liver disease: a prospective cohort study
Background: Cadmium (Cd) accumulates in the body over time, damaging organs such as the liver, kidneys, and brain. Some researchers have suggested that elevated blood Cd levels may contribute to the onset and progression of nonalcoholic fatty liver disease (NAFLD). However, only a few studies have explored the relationship between Cd exposure and long-term health outcomes in patients with NAFLD. This study aimed to evaluate the predictive value of blood cadmium levels for mortality risk in patients with NAFLD.Methods: This study analyzed data from 13,450 patients with NAFLD in the National Health and Nutrition Examination Survey (NHANES) database, covering the years 1999 to 2018. Patients were categorized into three groups based on their blood Cd levels. The relationship between blood cadmium concentrations and all-cause, cardiovascular, and cancer mortality in NAFLD patients was assessed using Cox proportional hazards regression while accounting for potential confounders. Results were visualized using Kaplan–Meier and restricted cubic spline (RCS) curves. Stratified analyses were performed for validation of the robustness of the results.Results: After adjusting for all covariates, blood Cd levels were positively associated with all-cause, cardiovascular, and cancer mortality in patients with NAFLD, showing a significant linear dose–response relationship. Specifically, for each unit increase in Log-transformed blood cadmium concentration, the risk of all-cause mortality increased by 191% (HR = 2.91, 95% CI: 2.39–3.53); cardiovascular mortality risk increased by 160% (HR = 2.6, 95% CI: 1.80–3.76); and cancer mortality risk increased by 279% (HR = 3.79, 95% CI: 2.54–5.65). Stratified analysis confirmed the robustness of these findings.Conclusion: Our study suggests that high Blood Cd levels adversely affect the prognosis of patients with NAFLD. Individuals with NAFLD should be aware of Cd exposure and take preventive measures. Moreover, stricter environmental protection policies may be necessary to reduce Cd exposure.
- Open Access
- 29 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (48) , e40643
Comparative analysis of triplanar Chevron osteotomy (TCO) and Chevron osteotomy (CO) for treating mild to moderate hallux valgus via computer simulation and 3D printing: An observational study
Hallux valgus (HV) deformity, which is characterized by lateral deviation and pronation of the metatarsophalangeal joint, demonstrates complex 3-dimensional challenges, thus prompting the development of various surgical approaches, including traditional Chevron osteotomy (CO) and novel triplanar Chevron osteotomy (TCO). The objective of this study is to determine TCO at various tilt angles by employing 3D printing for ex vivo osteotomy angle simulations and computer modeling to correct deformities across 3 planes, thus aiming to enhance surgical outcomes by preserving or even increasing the length of the first metatarsal and thereby overcoming the limitations of CO. In this study, we collected and analyzed non-weight-bearing CT data from 55 patients (61 feet) with mild-to-moderate hallux valgus, plantar callosities and metatarsalgia from June 2019 to June 2020. The study utilized Mimics software for 3D digital reconstructions and simulation osteotomy of both TCO and CO. For both procedures, the apex was centered at the first metatarsal head, with CO specifically oriented towards the fourth metatarsal head at a 60° angle. The plantar-oblique Chevron osteotomy (POCO) was defined by a 15° plantar tilt, whereas TCO involved a further 9° tilt towards the metatarsal head. The key metrics that were measured included the hallux valgus angle (HVA), 1–2 intermetatarsal angle (IMA), distal metatarsal articular angle (DMAA) and first metatarsal length (FML). Our study aged between 30 and 71 years, with an average age of 47.37 years. Postoperative assessments using Mimics software showed significant improvements in reducing the HVA, IMA, and DMAA after CO and TCO. However, when comparing both techniques, their corrective capacities were roughly equivalent, with no significant differences observed in these metrics. Notably, compared with CO, TCO significantly increased the FML (P < .001), thus suggesting that TCO has greater potential to effectively prevent transfer metatarsalgia. This study underscores the ability of TCO to significantly extend the first metatarsal, with precise adjustments to its distal tilt to tailor deformity corrections. In computational simulation experiments, TCO offers a superior alternative to CO for treating hallux valgus by addressing 3-dimensional deformities and preserving or even increasing FML, thereby preventing transfer metatarsalgia.
- 29 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (48) , e40643
Open AccessComparative analysis of triplanar Chevron osteotomy (TCO) and Chevron osteotomy (CO) for treating mild to moderate hallux valgus via computer simulation and 3D printing: An observational study
Hallux valgus (HV) deformity, which is characterized by lateral deviation and pronation of the metatarsophalangeal joint, demonstrates complex 3-dimensional challenges, thus prompting the development of various surgical approaches, including traditional Chevron osteotomy (CO) and novel triplanar Chevron osteotomy (TCO). The objective of this study is to determine TCO at various tilt angles by employing 3D printing for ex vivo osteotomy angle simulations and computer modeling to correct deformities across 3 planes, thus aiming to enhance surgical outcomes by preserving or even increasing the length of the first metatarsal and thereby overcoming the limitations of CO. In this study, we collected and analyzed non-weight-bearing CT data from 55 patients (61 feet) with mild-to-moderate hallux valgus, plantar callosities and metatarsalgia from June 2019 to June 2020. The study utilized Mimics software for 3D digital reconstructions and simulation osteotomy of both TCO and CO. For both procedures, the apex was centered at the first metatarsal head, with CO specifically oriented towards the fourth metatarsal head at a 60° angle. The plantar-oblique Chevron osteotomy (POCO) was defined by a 15° plantar tilt, whereas TCO involved a further 9° tilt towards the metatarsal head. The key metrics that were measured included the hallux valgus angle (HVA), 1–2 intermetatarsal angle (IMA), distal metatarsal articular angle (DMAA) and first metatarsal length (FML). Our study aged between 30 and 71 years, with an average age of 47.37 years. Postoperative assessments using Mimics software showed significant improvements in reducing the HVA, IMA, and DMAA after CO and TCO. However, when comparing both techniques, their corrective capacities were roughly equivalent, with no significant differences observed in these metrics. Notably, compared with CO, TCO significantly increased the FML (P < .001), thus suggesting that TCO has greater potential to effectively prevent transfer metatarsalgia. This study underscores the ability of TCO to significantly extend the first metatarsal, with precise adjustments to its distal tilt to tailor deformity corrections. In computational simulation experiments, TCO offers a superior alternative to CO for treating hallux valgus by addressing 3-dimensional deformities and preserving or even increasing FML, thereby preventing transfer metatarsalgia.
- Open Access
- 7 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-8
Nonlinear association between platelet to albumin ratio and disease activity in patients with early rheumatoid arthritis
The relationship between the platelet to albumin ratio (PAR) and the disease activity of early rheumatoid arthritis (ERA) remains to be elucidated. This cross-sectional study included 372 patients with ERA who were hospitalized at Xingtai People’s Hospital between January 2022 and January 2024. Multiple linear regression analysis was employed to assess the correlation of PAR with Disease Activity Score 28 (DAS28) using erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), and then generalized additive models were used to explore their relationship. After accounting for confounding variables, a positive correlation was observed between the PAR and DAS28-ESR and DAS28-CRP in ERA patients (β (95% CI): 0.20 (0.08, 0.32) and 0.20 (0.08, 0.33), respectively), and the general trends were consistent from the lowest tertile group (T1) to the highest tertile group (T3). Furthermore, a nonlinear relationship was identified between PAR and both DAS28-ESR and DAS28-CRP. Threshold effect analysis indicated that a value of 13.73 was a significant inflection point. In brief, PAR has a threshold effect on the disease activity of ERA. Increased PAR levels were independently positive associated with DAS28-ESR and DAS28-CRP among ERA patients with PAR < 13.73.
- 7 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-8
Open AccessNonlinear association between platelet to albumin ratio and disease activity in patients with early rheumatoid arthritis
The relationship between the platelet to albumin ratio (PAR) and the disease activity of early rheumatoid arthritis (ERA) remains to be elucidated. This cross-sectional study included 372 patients with ERA who were hospitalized at Xingtai People’s Hospital between January 2022 and January 2024. Multiple linear regression analysis was employed to assess the correlation of PAR with Disease Activity Score 28 (DAS28) using erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), and then generalized additive models were used to explore their relationship. After accounting for confounding variables, a positive correlation was observed between the PAR and DAS28-ESR and DAS28-CRP in ERA patients (β (95% CI): 0.20 (0.08, 0.32) and 0.20 (0.08, 0.33), respectively), and the general trends were consistent from the lowest tertile group (T1) to the highest tertile group (T3). Furthermore, a nonlinear relationship was identified between PAR and both DAS28-ESR and DAS28-CRP. Threshold effect analysis indicated that a value of 13.73 was a significant inflection point. In brief, PAR has a threshold effect on the disease activity of ERA. Increased PAR levels were independently positive associated with DAS28-ESR and DAS28-CRP among ERA patients with PAR < 13.73.
- RetractionOpen Access
- 21 May 2024
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 24 (3) , 1
Retraction Note: Breast cancer prognosis and immunological characteristics are predicted using the m6A/m5C/m1A/m7G-related long noncoding RNA signature
- 21 May 2024
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 24 (3) , 1
RetractionOpen AccessRetraction Note: Breast cancer prognosis and immunological characteristics are predicted using the m6A/m5C/m1A/m7G-related long noncoding RNA signature
- Open Access
- 5 October 2023
- Published by Springer Nature in Research Square
LASSO-Based Machine Learning Model for Prediction of Liver Failure in Hepatocellular Carcinoma Patients Undergoing TACE
PURPOSE Transcatheter arterial chemoembolization (TACE) is a commonly used method for the nonsurgical treatment of hepatocellular carcinoma (HCC); however, it can cause liver failure with rapid progression and high mortality. METHODS We organized and analyzed the data of patients with HCC undergoing TACE at our hospital. Screening indicators related to liver failure were analyzed using least absolute shrinkage and selection operator (LASSO) regression to establish a predictive model. RESULTS Prothrombin activity (odds ratio [OR] [95% confidence interval (CI)], 0.965 [0.931–0.997]; p = 0.040), tumor number (OR [95% CI], 2.328 [1.044–5.394]; p = 0.042), and vascular invasion (OR [95% CI], 2.778 [1.006–7.164]; p = 0.039) are independent risk factors for liver failure after TACE. The prediction model established based on these results had areas under the curve of 0.821 and 0.813 for the training and validation groups, respectively. CONCLUSION The prediction model established using LASSO regression can predict the risk of liver failure after TACE and confirm whether patients with advanced HCC can benefit from TACE.
- 5 October 2023
- Published by Springer Nature in Research Square
Open AccessLASSO-Based Machine Learning Model for Prediction of Liver Failure in Hepatocellular Carcinoma Patients Undergoing TACE
PURPOSE Transcatheter arterial chemoembolization (TACE) is a commonly used method for the nonsurgical treatment of hepatocellular carcinoma (HCC); however, it can cause liver failure with rapid progression and high mortality. METHODS We organized and analyzed the data of patients with HCC undergoing TACE at our hospital. Screening indicators related to liver failure were analyzed using least absolute shrinkage and selection operator (LASSO) regression to establish a predictive model. RESULTS Prothrombin activity (odds ratio [OR] [95% confidence interval (CI)], 0.965 [0.931–0.997]; p = 0.040), tumor number (OR [95% CI], 2.328 [1.044–5.394]; p = 0.042), and vascular invasion (OR [95% CI], 2.778 [1.006–7.164]; p = 0.039) are independent risk factors for liver failure after TACE. The prediction model established based on these results had areas under the curve of 0.821 and 0.813 for the training and validation groups, respectively. CONCLUSION The prediction model established using LASSO regression can predict the risk of liver failure after TACE and confirm whether patients with advanced HCC can benefit from TACE.
- Retracted
- 4 April 2023
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 23 (2) , 1-14
RETRACTED ARTICLE: Breast cancer prognosis and immunological characteristics are predicted using the m6A/m5C/m1A/m7G-related long noncoding RNA signature
- 4 April 2023
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 23 (2) , 1-14
RetractedRETRACTED ARTICLE: Breast cancer prognosis and immunological characteristics are predicted using the m6A/m5C/m1A/m7G-related long noncoding RNA signature
- Open Access
- 12 January 2023
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 29 (3) , 520-528
Inversed albumin-to-globulin ratio and underlying liver disease severity as a prognostic factor for survival in hepatocellular carcinoma patients undergoing transarterial chemoembolization
PURPOSE Previous studies have shown that an inversed albumin-to-globulin ratio (IAGR) is a predictor of the prognosis of many cancers. However, the prognostic value of an IAGR for patients with hepatocellu-lar carcinoma (HCC) who undergo transarterial chemoembolization (TACE) is still unclear. This study aims to evaluate the predictive value of an IAGR for the prognosis of those patients. METHODS This study retrospectively analyzed 396 patients with HCC who received TACE. Using a cut-off value of 1.0 for the albumin-to-globulin ratio, patients were divided into a normal albumin-to-globulin ratio (NAGR) (& GE;1) and an IAGR (<1) group. Univariate and multivariate analyses and time -depen-dent receiver operating characteristic analyses were performed to identify risk factors of overall survival (OS) and cancer-specific survival (CSS). Survival nomograms were constructed based on the multivariable analysis results and further evaluated using the consistency index (C-index) and calibration curve. RESULTS A total of 396 patients were included in the final analysis and were divided into the NAGR group (n = 298, 75.3%) and the IAGR (n = 98, 24.7%) group. The median OS and CSS were significantly worse in the IAGR group than in the NAGR group (OS: 8 vs. 26 months, CSS: 10 vs. 41 months, both P < 0.001). Multivariate analyses demonstrated that an IAGR was an independent risk factor for predicting worse OS [hazard ratio (HR), 2.024; 95% confidence interval (CI): 1.460-2.806] and CSS (HR: 2.439; 95% CI: 1.651-3.601). The nomogram-based model-related C-indexes for OS and CSS prediction were 0.715 (95% CI: 0.697-0.733) and 0.750 (95% CI: 0.729-0.771), and the calibration of the nomogram showed good consistency. CONCLUSION The IAGR along with underlying liver disease severity were the useful prognostic predictors of OS and CSS among patients with HCC undergoing TACE and might be useful to identify high-risk pa-tients.
- 12 January 2023
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 29 (3) , 520-528
Open AccessInversed albumin-to-globulin ratio and underlying liver disease severity as a prognostic factor for survival in hepatocellular carcinoma patients undergoing transarterial chemoembolization
PURPOSE Previous studies have shown that an inversed albumin-to-globulin ratio (IAGR) is a predictor of the prognosis of many cancers. However, the prognostic value of an IAGR for patients with hepatocellu-lar carcinoma (HCC) who undergo transarterial chemoembolization (TACE) is still unclear. This study aims to evaluate the predictive value of an IAGR for the prognosis of those patients. METHODS This study retrospectively analyzed 396 patients with HCC who received TACE. Using a cut-off value of 1.0 for the albumin-to-globulin ratio, patients were divided into a normal albumin-to-globulin ratio (NAGR) (& GE;1) and an IAGR (<1) group. Univariate and multivariate analyses and time -depen-dent receiver operating characteristic analyses were performed to identify risk factors of overall survival (OS) and cancer-specific survival (CSS). Survival nomograms were constructed based on the multivariable analysis results and further evaluated using the consistency index (C-index) and calibration curve. RESULTS A total of 396 patients were included in the final analysis and were divided into the NAGR group (n = 298, 75.3%) and the IAGR (n = 98, 24.7%) group. The median OS and CSS were significantly worse in the IAGR group than in the NAGR group (OS: 8 vs. 26 months, CSS: 10 vs. 41 months, both P < 0.001). Multivariate analyses demonstrated that an IAGR was an independent risk factor for predicting worse OS [hazard ratio (HR), 2.024; 95% confidence interval (CI): 1.460-2.806] and CSS (HR: 2.439; 95% CI: 1.651-3.601). The nomogram-based model-related C-indexes for OS and CSS prediction were 0.715 (95% CI: 0.697-0.733) and 0.750 (95% CI: 0.729-0.771), and the calibration of the nomogram showed good consistency. CONCLUSION The IAGR along with underlying liver disease severity were the useful prognostic predictors of OS and CSS among patients with HCC undergoing TACE and might be useful to identify high-risk pa-tients.